// App-Quantinova.ai

T058 : Three year real‐life outcomes from the use of the fluocinolone acetonide implant (Iluvien) in the treatment of refractory DMO

Researchers

Presenter

  • E. Karatsai

Principal Investigators

  • Y. Ali

  • S. Taylor

Medical Centers

  • Royal Surrey County Hospital, Guildford, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Fluocinolone Acetonide

  • Fluocinolone

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved